NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
Top holders
| Fund | Weight (%) | Value |
|---|---|---|
| DODGXDodge & Cox Stock Fund Class I | 0.6 | $668M |
| IJHiShares Core S&P Mid-Cap ETF | 0.5 | $580M |
| VTIVanguard Morningstar Total Stock Market ETF | 0.0 | $538M |
| VBVanguard Morningstar Small-Cap ETF | 0.2 | $388M |
| JGACXJPMorgan Growth Advantage Fund Class C | 1.0 | $229M |
| VBKVanguard Morningstar Small-Cap Growth ETF | 0.5 | $224M |
| VXFVanguard Extended Market ETF | 0.2 | $194M |
| HLGEXJPMorgan Mid Cap Growth Fund Class I | 1.4 | $188M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | 0.5 | $130M |
| IBBiShares Biotechnology ETF | 1.3 | $118M |
Holders
- Funds
- 220
- Held in all
- $5.87B
- Held by the top 10
- 55.5%
- Highest weight
- FBT3.5%